Cargando…
Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma
Endometrial carcinosarcoma (ECS) represents one of the most extreme examples of tumor heterogeneity among human cancers. ECS is a clinically aggressive, high-grade, metaplastic carcinoma. At the morphological level, intratumor heterogeneity in ECS is due to an admixture of epithelial (carcinoma) and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678708/ https://www.ncbi.nlm.nih.gov/pubmed/31324031 http://dx.doi.org/10.3390/cancers11070964 |
_version_ | 1783441165486391296 |
---|---|
author | Leskela, Susanna Pérez-Mies, Belen Rosa-Rosa, Juan Manuel Cristobal, Eva Biscuola, Michele Palacios-Berraquero, María L. Ong, SuFey Matias-Guiu Guia, Xavier Palacios, José |
author_facet | Leskela, Susanna Pérez-Mies, Belen Rosa-Rosa, Juan Manuel Cristobal, Eva Biscuola, Michele Palacios-Berraquero, María L. Ong, SuFey Matias-Guiu Guia, Xavier Palacios, José |
author_sort | Leskela, Susanna |
collection | PubMed |
description | Endometrial carcinosarcoma (ECS) represents one of the most extreme examples of tumor heterogeneity among human cancers. ECS is a clinically aggressive, high-grade, metaplastic carcinoma. At the morphological level, intratumor heterogeneity in ECS is due to an admixture of epithelial (carcinoma) and mesenchymal (sarcoma) components that can include heterologous tissues, such as skeletal muscle, cartilage, or bone. Most ECSs belong to the copy-number high serous-like molecular subtype of endometrial carcinoma, characterized by the TP53 mutation and the frequently accompanied by a large number of gene copy-number alterations, including the amplification of important oncogenes, such as CCNE1 and c-MYC. However, a proportion of cases (20%) probably represent the progression of tumors initially belonging to the copy-number low endometrioid-like molecular subtype (characterized by mutations in genes such as PTEN, PI3KCA, or ARID1A), after the acquisition of the TP53 mutations. Only a few ECS belong to the microsatellite-unstable hypermutated molecular type and the POLE-mutated, ultramutated molecular type. A common characteristic of all ECSs is the modulation of genes involved in the epithelial to mesenchymal process. Thus, the acquisition of a mesenchymal phenotype is associated with a switch from E- to N-cadherin, the up-regulation of transcriptional repressors of E-cadherin, such as Snail Family Transcriptional Repressor 1 and 2 (SNAI1 and SNAI2), Zinc Finger E-Box Binding Homeobox 1 and 2 (ZEB1 and ZEB2), and the down-regulation, among others, of members of the miR-200 family involved in the maintenance of an epithelial phenotype. Subsequent differentiation to different types of mesenchymal tissues increases tumor heterogeneity and probably modulates clinical behavior and therapy response. |
format | Online Article Text |
id | pubmed-6678708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66787082019-08-19 Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma Leskela, Susanna Pérez-Mies, Belen Rosa-Rosa, Juan Manuel Cristobal, Eva Biscuola, Michele Palacios-Berraquero, María L. Ong, SuFey Matias-Guiu Guia, Xavier Palacios, José Cancers (Basel) Review Endometrial carcinosarcoma (ECS) represents one of the most extreme examples of tumor heterogeneity among human cancers. ECS is a clinically aggressive, high-grade, metaplastic carcinoma. At the morphological level, intratumor heterogeneity in ECS is due to an admixture of epithelial (carcinoma) and mesenchymal (sarcoma) components that can include heterologous tissues, such as skeletal muscle, cartilage, or bone. Most ECSs belong to the copy-number high serous-like molecular subtype of endometrial carcinoma, characterized by the TP53 mutation and the frequently accompanied by a large number of gene copy-number alterations, including the amplification of important oncogenes, such as CCNE1 and c-MYC. However, a proportion of cases (20%) probably represent the progression of tumors initially belonging to the copy-number low endometrioid-like molecular subtype (characterized by mutations in genes such as PTEN, PI3KCA, or ARID1A), after the acquisition of the TP53 mutations. Only a few ECS belong to the microsatellite-unstable hypermutated molecular type and the POLE-mutated, ultramutated molecular type. A common characteristic of all ECSs is the modulation of genes involved in the epithelial to mesenchymal process. Thus, the acquisition of a mesenchymal phenotype is associated with a switch from E- to N-cadherin, the up-regulation of transcriptional repressors of E-cadherin, such as Snail Family Transcriptional Repressor 1 and 2 (SNAI1 and SNAI2), Zinc Finger E-Box Binding Homeobox 1 and 2 (ZEB1 and ZEB2), and the down-regulation, among others, of members of the miR-200 family involved in the maintenance of an epithelial phenotype. Subsequent differentiation to different types of mesenchymal tissues increases tumor heterogeneity and probably modulates clinical behavior and therapy response. MDPI 2019-07-09 /pmc/articles/PMC6678708/ /pubmed/31324031 http://dx.doi.org/10.3390/cancers11070964 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Leskela, Susanna Pérez-Mies, Belen Rosa-Rosa, Juan Manuel Cristobal, Eva Biscuola, Michele Palacios-Berraquero, María L. Ong, SuFey Matias-Guiu Guia, Xavier Palacios, José Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title | Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title_full | Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title_fullStr | Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title_full_unstemmed | Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title_short | Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma |
title_sort | molecular basis of tumor heterogeneity in endometrial carcinosarcoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678708/ https://www.ncbi.nlm.nih.gov/pubmed/31324031 http://dx.doi.org/10.3390/cancers11070964 |
work_keys_str_mv | AT leskelasusanna molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT perezmiesbelen molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT rosarosajuanmanuel molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT cristobaleva molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT biscuolamichele molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT palaciosberraqueromarial molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT ongsufey molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT matiasguiuguiaxavier molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma AT palaciosjose molecularbasisoftumorheterogeneityinendometrialcarcinosarcoma |